Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
CNS Drugs|November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort StudyValeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Frontiers in Neurology|September 22, 2025
Sex differences in the clinical features of 2,841 patients with migraine: a <i>post-hoc</i>, multicenter, cross-sectional studyMarina Romozzi, Luigi Francesco Iannone, Marcello Silvestro, et al.
Neurobiology of Aging|July 9, 2015
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementiaRaffaele Ferrari, Mario Grassi, Erika Salvi, et al.
Archives of Neurology|September 12, 2012
Investigation of c9orf72 in 4 neurodegenerative disordersZhengrui Xi, Lorne Zinman, Yakov Grinberg, et al.
Cephalalgia : an International Journal of Headache|June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Cephalalgia : an International Journal of Headache|February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Biological Psychiatry|March 12, 2013
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentationDaniela Galimberti, Chiara Fenoglio, Maria Serpente, et al.
Cephalalgia : an International Journal of Headache|March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerabilityLuigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
Nature Genetics|January 16, 2007
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseEkaterina Rogaeva, Yan Meng, Joseph H Lee, et al.
The Journal of Headache and Pain|October 2, 2025
Hallmarks of primary headache: part 3 - cluster headacheGianluca Coppola, Marco Antônio Arruda, Messoud Ashina, et al.
Pageof 18